Tiempo de Vacunarte (time to get vaccinated): Outcomes of an intervention to improve HPV vaccination rates in a predominantly Hispanic community

Cancer statistics, 2011

Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjosé, Wim Quint, Laia Alemany et al. · The Lancet Oncology · 2010 · 2.7K citations

Medicine, Genetics, Oncology +16

Human Papillomavirus–Associated Cancers — United States, 2008–2012

Laura Viens, S. Jane Henley, Meg Watson et al. · MMWR Morbidity and Mortality Weekly Report · 2016 · 878 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen, Jorma Paavonen, Cosette M. Wheeler et al. · The Lancet Oncology · 2011 · 703 citations

Medicine, Gynecology, Oncology +15

Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPV

Amanda F. Dempsey, Gregory D. Zimet, Robert L. Davis et al. · PEDIATRICS · 2006 · 490 citations

Public Health, Child Health, Pediatrics +16